196 related articles for article (PubMed ID: 32094134)
1. Novel Endochin-Like Quinolones Exhibit Potent
van Schalkwyk DA; Riscoe MK; Pou S; Winter RW; Nilsen A; Duffey M; Moon RW; Sutherland CJ
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094134
[TBL] [Abstract][Full Text] [Related]
2. Atovaquone and ELQ-300 Combination Therapy as a Novel Dual-Site Cytochrome bc1 Inhibition Strategy for Malaria.
Stickles AM; Smilkstein MJ; Morrisey JM; Li Y; Forquer IP; Kelly JX; Pou S; Winter RW; Nilsen A; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2016 Aug; 60(8):4853-9. PubMed ID: 27270285
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents.
van Schalkwyk DA; Moon RW; Blasco B; Sutherland CJ
J Antimicrob Chemother; 2017 Nov; 72(11):3051-3058. PubMed ID: 28961865
[TBL] [Abstract][Full Text] [Related]
4. Plasmodium knowlesi exhibits distinct in vitro drug susceptibility profiles from those of Plasmodium falciparum.
van Schalkwyk DA; Blasco B; Davina Nuñez R; Liew JWK; Amir A; Lau YL; Leroy D; Moon RW; Sutherland CJ
Int J Parasitol Drugs Drug Resist; 2019 Apr; 9():93-99. PubMed ID: 30831468
[TBL] [Abstract][Full Text] [Related]
5. Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum.
Fivelman QL; Adagu IS; Warhurst DC
Antimicrob Agents Chemother; 2004 Nov; 48(11):4097-102. PubMed ID: 15504827
[TBL] [Abstract][Full Text] [Related]
6. Quinolone-3-diarylethers: a new class of antimalarial drug.
Nilsen A; LaCrue AN; White KL; Forquer IP; Cross RM; Marfurt J; Mather MW; Delves MJ; Shackleford DM; Saenz FE; Morrisey JM; Steuten J; Mutka T; Li Y; Wirjanata G; Ryan E; Duffy S; Kelly JX; Sebayang BF; Zeeman AM; Noviyanti R; Sinden RE; Kocken CHM; Price RN; Avery VM; Angulo-Barturen I; Jiménez-Díaz MB; Ferrer S; Herreros E; Sanz LM; Gamo FJ; Bathurst I; Burrows JN; Siegl P; Guy RK; Winter RW; Vaidya AB; Charman SA; Kyle DE; Manetsch R; Riscoe MK
Sci Transl Med; 2013 Mar; 5(177):177ra37. PubMed ID: 23515079
[TBL] [Abstract][Full Text] [Related]
7. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand.
Khositnithikul R; Tan-Ariya P; Mungthin M
Malar J; 2008 Jan; 7():23. PubMed ID: 18226262
[TBL] [Abstract][Full Text] [Related]
8. Cyclization-blocked proguanil as a strategy to improve the antimalarial activity of atovaquone.
Skinner-Adams TS; Fisher GM; Riches AG; Hutt OE; Jarvis KE; Wilson T; von Itzstein M; Chopra P; Antonova-Koch Y; Meister S; Winzeler EA; Clarke M; Fidock DA; Burrows JN; Ryan JH; Andrews KT
Commun Biol; 2019; 2():166. PubMed ID: 31069275
[TBL] [Abstract][Full Text] [Related]
9. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic interaction between atovaquone and other antimalarial compounds against Plasmodium falciparum in vitro.
Lütgendorf C; Rojanawatsirivet C; Wernsdorfer G; Sirichaisinthop J; Kollaritsch H; Wernsdorfer WH
Wien Klin Wochenschr; 2006; 118(19-20 Suppl 3):70-6. PubMed ID: 17131244
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial quinolones: synthesis, potency, and mechanistic studies.
Winter RW; Kelly JX; Smilkstein MJ; Dodean R; Hinrichs D; Riscoe MK
Exp Parasitol; 2008 Apr; 118(4):487-97. PubMed ID: 18082162
[TBL] [Abstract][Full Text] [Related]
12. Role of Trifluoromethyl Substitution in Design of Antimalarial Quinolones: a Comprehensive Review.
Romero AH
Top Curr Chem (Cham); 2019 Mar; 377(2):9. PubMed ID: 30835005
[TBL] [Abstract][Full Text] [Related]
13. Adaptation of the [3H]Hypoxanthine Uptake Assay for In Vitro-Cultured Plasmodium knowlesi Malaria Parasites.
Arnold MS; Engel JA; Chua MJ; Fisher GM; Skinner-Adams TS; Andrews KT
Antimicrob Agents Chemother; 2016 Jul; 60(7):4361-3. PubMed ID: 27114276
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamic interactions among atovaquone, proguanil and cycloguanil against Plasmodium falciparum in vitro.
Thapar MM; Gupta S; Spindler C; Wernsdorfer WH; Björkman A
Trans R Soc Trop Med Hyg; 2003; 97(3):331-7. PubMed ID: 15228254
[TBL] [Abstract][Full Text] [Related]
15. Discovery, synthesis, and optimization of antimalarial 4(1H)-quinolone-3-diarylethers.
Nilsen A; Miley GP; Forquer IP; Mather MW; Katneni K; Li Y; Pou S; Pershing AM; Stickles AM; Ryan E; Kelly JX; Doggett JS; White KL; Hinrichs DJ; Winter RW; Charman SA; Zakharov LN; Bathurst I; Burrows JN; Vaidya AB; Riscoe MK
J Med Chem; 2014 May; 57(9):3818-34. PubMed ID: 24720377
[TBL] [Abstract][Full Text] [Related]
16. Subtle changes in endochin-like quinolone structure alter the site of inhibition within the cytochrome bc1 complex of Plasmodium falciparum.
Stickles AM; de Almeida MJ; Morrisey JM; Sheridan KA; Forquer IP; Nilsen A; Winter RW; Burrows JN; Fidock DA; Vaidya AB; Riscoe MK
Antimicrob Agents Chemother; 2015 Apr; 59(4):1977-82. PubMed ID: 25605352
[TBL] [Abstract][Full Text] [Related]
17. Optimization of endochin-like quinolones for antimalarial activity.
Winter R; Kelly JX; Smilkstein MJ; Hinrichs D; Koop DR; Riscoe MK
Exp Parasitol; 2011 Feb; 127(2):545-51. PubMed ID: 21040724
[TBL] [Abstract][Full Text] [Related]
18. The activity of triple combinations of antifolate biguanides, with and without folinic acid, against plasmodium falciparum in vitro.
Yeo AE; Rieckmann KH
Ann Trop Med Parasitol; 1997 Apr; 91(3):247-51. PubMed ID: 9229018
[TBL] [Abstract][Full Text] [Related]
19. Targeted Structure-Activity Analysis of Endochin-like Quinolones Reveals Potent Qi and Qo Site Inhibitors of Toxoplasma gondii and Plasmodium falciparum Cytochrome bc
McConnell EV; Bruzual I; Pou S; Winter R; Dodean RA; Smilkstein MJ; Krollenbrock A; Nilsen A; Zakharov LN; Riscoe MK; Doggett JS
ACS Infect Dis; 2018 Nov; 4(11):1574-1584. PubMed ID: 30117728
[TBL] [Abstract][Full Text] [Related]
20. Atovaquone tolerance in Plasmodium falciparum parasites selected for high-level resistance to a dihydroorotate dehydrogenase inhibitor.
Guler JL; White J; Phillips MA; Rathod PK
Antimicrob Agents Chemother; 2015 Jan; 59(1):686-9. PubMed ID: 25331708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
